Neogen Chemicals IPO: Here's why analysts have mixed recommendations
Updated : April 24, 2019 12:38 PM IST
Through the IPO, Neogen Chemicals is looking to raise about Rs 70 crore by issuing fresh equity shares, with promoters offloading 29 lakh shares.
Anand Rathi recommends ‘Subscribe’ considering the company’s ability to grow profitably and command better return ratios.
Choice Broking Research says ‘Avoid’ the IPO as it is valued at a P/E multiple of 47.8x which is at a premium to its peer average of 38.8x.
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morning
YOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more